Find Diatrizoate Sodium manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

0INTERMEDIATES

0 DRUGS IN DEVELOPMENT

FDF DossiersDRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

3 RELATED EXCIPIENT COMPANIES

2EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Sodium diatrizoate, 737-31-5, Sodium amidotrizoate, Triombrine, Hypaque sodium, Diatrizoic acid sodium salt
Molecular Formula
C11H8I3N2NaO4
Molecular Weight
635.89  g/mol
InChI Key
ZEYOIOAKZLALAP-UHFFFAOYSA-M
FDA UNII
V5403H8VG7

Diatrizoate Sodium
Diatrizoate Sodium is an iodinated radiopaque X-ray contrast medium. Diatrizoate sodium blocks X-rays, thereby allowing body structures containing iodine to be delineated in contrast to those structures that do not contain iodine and allowing visualization of these areas. This contrast agent is used as a diagnostic aid in angiography, urography and radiography. (NCI05)
1 2D Structure

Diatrizoate Sodium

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
sodium;3,5-diacetamido-2,4,6-triiodobenzoate
2.1.2 InChI
InChI=1S/C11H9I3N2O4.Na/c1-3(17)15-9-6(12)5(11(19)20)7(13)10(8(9)14)16-4(2)18;/h1-2H3,(H,15,17)(H,16,18)(H,19,20);/q;+1/p-1
2.1.3 InChI Key
ZEYOIOAKZLALAP-UHFFFAOYSA-M
2.1.4 Canonical SMILES
CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)NC(=O)C)I.[Na+]
2.2 Other Identifiers
2.2.1 UNII
V5403H8VG7
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Sodium Diatrizoate

2. 737-31-5

3. Sodium Amidotrizoate

4. Triombrine

5. Hypaque Sodium

6. Diatrizoic Acid Sodium Salt

7. Sodium 3,5-diacetamido-2,4,6-triiodobenzoate

8. Triombrin

9. Natrii Amidotrizoas

10. Vascoray

11. Conray 35

12. Hypaque Cysto

13. Hpaque - Cysto

14. Amidotrizoato Sodico

15. Histopaque

16. Hypaque Sodium 20%

17. Urovist Sodium

18. Diatrizoate Sodium Salt

19. Amidotrizoate De Sodium

20. Benzoic Acid, 3,5-bis(acetylamino)-2,4,6-triiodo-, Monosodium Salt

21. Hypaque 50

22. Md 50

23. Sodium Diacetyldiaminetriiodobenzoate

24. Sodium Amidotrizoate (inn)

25. Urographing 370

26. Monosodium 3,5-diacetamido-2,4,6-triiodobenzoate

27. Urografic Acid, Sodium Salt

28. Diatrizoate Sodium [usp]

29. Sodium Amidotrizoate [inn]

30. Ml 216

31. Win 8308-3

32. 3,5-diacetamido-2,4,6-triiodobenzoic Acid Sodium Salt

33. Md-50

34. Mls000069526

35. Chebi:53692

36. V5403h8vg7

37. Gastrografin

38. 3,5-diacetylamino-2,4,6-trijodbenzosaeure Natrium

39. Nsc-61815

40. Smr000058586

41. Diatrizoate Sodium (usp)

42. Sodium;3,5-diacetamido-2,4,6-triiodobenzoate

43. Diatrizoic Acid Sodium Salt;sodium Amidotrizoate

44. Benzoic Acid, 3,5-diacetamido-2,4,6-triiodo-, Monosodium Salt

45. Urovist Sodium 300

46. Radioselectan

47. Urovist 300

48. Natrii Amidotrizoas [inn-latin]

49. Amidotrizoato Sodico [inn-spanish]

50. Einecs 212-004-1

51. Nsc 61815

52. Amidotrizoate De Sodium [inn-french]

53. Renografin 76 Injectable (veterinary)

54. Unii-v5403h8vg7

55. Hsdb 8078

56. 3,5-diacetamido-2,4,6-triiodobenzoic Acid, Sodium Salt

57. Urovist Sodium (tn)

58. 3,5-diacetylamino-2,4,6-trijodbenzosaeure Natrium [german]

59. Benzoic Acid, 3,5-diacetamido-2,4,6-triiodo-, Sodium Salt

60. Opera_id_214

61. Dsstox_cid_2912

62. Sodium Diatrizoate [ban]

63. Dsstox_rid_76785

64. Dsstox_gsid_22912

65. Schembl37116

66. Chembl1200581

67. Dtxsid7022912

68. Hy-b0926a

69. Diatrizoate Sodium [vandf]

70. Diatrizoate Sodium [who-ip]

71. Tox21_301439

72. Diatrizoic Acid Sodium Salt Dihydrate

73. Sodium Amidotrizoate [mart.]

74. Sodium Amidotrizoate [who-dd]

75. Sodium Amidotrizoate [who-ip]

76. Akos024371067

77. Ccg-270302

78. Diatrizoate Sodium [green Book]

79. Diatrizoate Sodium [orange Book]

80. Diatrizoic Acid Sodium Salt [mi]

81. Ncgc00255327-01

82. Cas-737-31-5

83. Diatrizoate Sodium [usp Monograph]

84. Sodium Amidotrizoate [ep Impurity]

85. Natrii Amidotrizoas [who-ip Latin]

86. Renocal Component Diatrizoate Sodium

87. Sodium Amidotrizoate [ep Monograph]

88. Renovist Component Diatrizoate Sodium

89. Angiovist Component Diatrizoate Sodium

90. Cs-0013563

91. Ft-0603095

92. Diatrizoate Sodium Component Of Renocal

93. Gastrovist Component Diatrizoate Sodium

94. Renografin Component Diatrizoate Sodium

95. Sodium3,5-diacetamido-2,4,6-triiodobenzoate

96. A17075

97. D01013

98. D97593

99. Diatrizoate Sodium Component Of Renovist

100. Gastrografin Component Diatrizoate Sodium

101. Diatrizoate Sodium Component Of Angiovist

102. Diatrizoate Sodium Component Of Gastrovist

103. Diatrizoate Sodium Component Of Renografin

104. Md-gastroview Component Diatrizoate Sodium

105. Diatrizoate Sodium Component Of Gastrografin

106. Diatrizoate Sodium Component Of Md-gastroview

107. Sodium 3,5-bis(acetylamino)-2,4,6-triiodobenzoate

108. 3,5-diacetamido-2,4,6-tiiodobenzoic Acid Sodium Salt

109. Q27104811

2.4 Create Date
2008-02-05
3 Chemical and Physical Properties
Molecular Weight 635.89 g/mol
Molecular Formula C11H8I3N2NaO4
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count4
Rotatable Bond Count3
Exact Mass635.7516 g/mol
Monoisotopic Mass635.7516 g/mol
Topological Polar Surface Area98.3 Ų
Heavy Atom Count21
Formal Charge0
Complexity396
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Therapeutic Uses

GLOFIL-125 (Sodium Iothalamate I-125 Injection) is indicated for evaluation of glomerular filtration in the diagnosis or monitoring of patients with renal disease.

US Natl Inst Health; DailyMed. Current Medication Information for Glofil-125 (iothalamate sodium, I-125) Injection (June 2007). Available from, as of July 23, 2012: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2c07ce91-cc83-45e3-bd2b-f923a9c8286c


4.2 Drug Warning

Contrast Media

National Library of Medicine's Medical Subject Headings online file (MeSH, 2009)


As in the use of any radioactive material, care should be taken to minimize radiation exposure to the patient, consistent with proper patient management, and to insure minimum radiation exposure to occupational workers.

US Natl Inst Health; DailyMed. Current Medication Information for Glofil-125 (iothalamate sodium, I-125) Injection (June 2007). Available from, as of July 23, 2012: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2c07ce91-cc83-45e3-bd2b-f923a9c8286c


Rapid or bolus-like injections should be avoided.

US Natl Inst Health; DailyMed. Current Medication Information for Glofil-125 (iothalamate sodium, I-125) Injection (June 2007). Available from, as of July 23, 2012: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2c07ce91-cc83-45e3-bd2b-f923a9c8286c


Radiopharmaceuticals should be used only by physicians who are qualified by training and experience in the safe use and handling of radionuclides.

US Natl Inst Health; DailyMed. Current Medication Information for Glofil-125 (iothalamate sodium, I-125) Injection (June 2007). Available from, as of July 23, 2012: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2c07ce91-cc83-45e3-bd2b-f923a9c8286c


For more Drug Warnings (Complete) data for Iothalamate (8 total), please visit the HSDB record page.


5 Pharmacology and Biochemistry
5.1 Absorption, Distribution and Excretion

Radioiodine is excreted in human milk during lactation. It is not known whether GLOFIL-125 is excreted in human milk.

US Natl Inst Health; DailyMed. Current Medication Information for Glofil-125 (iothalamate sodium, I-125) Injection (June 2007). Available from, as of July 23, 2012: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2c07ce91-cc83-45e3-bd2b-f923a9c8286c


The renal clearance of sodium iothalamate in man closely approximates that of inulin. The compound is cleared by glomerular filtration without tubular secretion or reabsorption.

US Natl Inst Health; DailyMed. Current Medication Information for Glofil-125 (iothalamate sodium, I-125) Injection (June 2007). Available from, as of July 23, 2012: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2c07ce91-cc83-45e3-bd2b-f923a9c8286c


5.2 Biological Half-Life

Following infusion administration of I-125 iothalamate, the effective half-life is about 0.07 days.

US Natl Inst Health; DailyMed. Current Medication Information for Glofil-125 (iothalamate sodium, I-125) Injection (June 2007). Available from, as of July 23, 2012: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2c07ce91-cc83-45e3-bd2b-f923a9c8286c


API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1697394600,"product":"DIATRIZOATE SODIUM USPACTIVE PHARMACEUTICAL INGREDIENT(REF NO:2301260666 DT:12.10.2023)","address":"78\/A,VENGALARAO NAGAR","city":"ANDHRA PRADESH","supplier":"VASUDHA PHARMA CHEM","supplierCountry":"INDIA","foreign_port":"SEOUL","customer":"TO THE ORDER OF","customerCountry":"KOREA, REPUBLIC OF","quantity":"50.00","actualQuantity":"50","unit":"KGS","unitRateFc":"170","totalValueFC":"8350.4","currency":"USD","unitRateINR":13900,"date":"16-Oct-2023","totalValueINR":"695000","totalValueInUsd":"8350.4","indian_port":"Hyderabad Air","hs_no":"29163990","bill_no":"4664927","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"78\/A,VENGALARAO NAGAR, ANDHRA PRADESH","customerAddress":""}]
16-Oct-2023
16-Oct-2023
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - SOLUTION;ORAL, RECTAL - 66%;10%

USFDA APPLICATION NUMBER - 11245

read-more

DOSAGE - INJECTABLE;INJECTION - 66%;10%

USFDA APPLICATION NUMBER - 19292

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Diatrizoate Sodium Manufacturers

A Diatrizoate Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Diatrizoate Sodium, including repackagers and relabelers. The FDA regulates Diatrizoate Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Diatrizoate Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Diatrizoate Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Diatrizoate Sodium Suppliers

A Diatrizoate Sodium supplier is an individual or a company that provides Diatrizoate Sodium active pharmaceutical ingredient (API) or Diatrizoate Sodium finished formulations upon request. The Diatrizoate Sodium suppliers may include Diatrizoate Sodium API manufacturers, exporters, distributors and traders.

click here to find a list of Diatrizoate Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Diatrizoate Sodium USDMF

A Diatrizoate Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Diatrizoate Sodium active pharmaceutical ingredient (API) in detail. Different forms of Diatrizoate Sodium DMFs exist exist since differing nations have different regulations, such as Diatrizoate Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Diatrizoate Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Diatrizoate Sodium USDMF includes data on Diatrizoate Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Diatrizoate Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Diatrizoate Sodium suppliers with USDMF on PharmaCompass.

Diatrizoate Sodium WC

A Diatrizoate Sodium written confirmation (Diatrizoate Sodium WC) is an official document issued by a regulatory agency to a Diatrizoate Sodium manufacturer, verifying that the manufacturing facility of a Diatrizoate Sodium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Diatrizoate Sodium APIs or Diatrizoate Sodium finished pharmaceutical products to another nation, regulatory agencies frequently require a Diatrizoate Sodium WC (written confirmation) as part of the regulatory process.

click here to find a list of Diatrizoate Sodium suppliers with Written Confirmation (WC) on PharmaCompass.

Diatrizoate Sodium NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Diatrizoate Sodium as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Diatrizoate Sodium API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Diatrizoate Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Diatrizoate Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Diatrizoate Sodium NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Diatrizoate Sodium suppliers with NDC on PharmaCompass.

Diatrizoate Sodium GMP

Diatrizoate Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Diatrizoate Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Diatrizoate Sodium GMP manufacturer or Diatrizoate Sodium GMP API supplier for your needs.

Diatrizoate Sodium CoA

A Diatrizoate Sodium CoA (Certificate of Analysis) is a formal document that attests to Diatrizoate Sodium's compliance with Diatrizoate Sodium specifications and serves as a tool for batch-level quality control.

Diatrizoate Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Diatrizoate Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Diatrizoate Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Diatrizoate Sodium EP), Diatrizoate Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Diatrizoate Sodium USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty